Approximately 45 000 volunteers are partaking in the trial, and results are expected in February 2021
J&J also became the first of the vaccine developers to apply for Covid vaccine registration in SA, SAHPRA confirmed on Monday
Pharmaceutical company Johnson & Johnson’s large-scale Phase 3 Covid-19 vaccine clinical trial (ENSEMBLE) of their Janssen single-dose vaccine candidate is now fully enrolled with approximately 45 000 participants, the company announced on Thursday.
“Given the high incidence of Covid-19 among the general population in the countries where the trial is being conducted, this number of participants will be sufficient to generate the data needed to determine the efficacy and safety of the Company’s investigational Covid-19 vaccine candidate,” they stated.